Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD: JACC Review Topic of the Week
Ticagrelor is a cornerstone of modern antithrombotic therapy alongside aspirin in patients
with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects …
with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects …
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
F D'Ascenzo, O De Filippo, G Gallone, G Mittone… - The Lancet, 2021 - thelancet.com
Background The accuracy of current prediction tools for ischaemic and bleeding events after
an acute coronary syndrome (ACS) remains insufficient for individualised patient …
an acute coronary syndrome (ACS) remains insufficient for individualised patient …
Therapy discontinuation after myocardial infarction
Ł Pietrzykowski, M Kasprzak, P Michalski… - Journal of Clinical …, 2020 - mdpi.com
The discontinuation of recommended therapy after myocardial infarction predisposes
patients to serious thrombotic complications. The aim of this study was a comprehensive …
patients to serious thrombotic complications. The aim of this study was a comprehensive …
Dyspnea-related ticagrelor discontinuation after percutaneous coronary intervention
Background Nearly 20% of patients on ticagrelor experience dyspnea, which may lead to
treatment discontinuation in up to one-third of cases. Objectives The authors sought to …
treatment discontinuation in up to one-third of cases. Objectives The authors sought to …
Ticagrelor versus prasugrel for the treatment of patients with type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta …
H Yang, B Tang, CH Xu, A Ahmed - Diabetes Therapy, 2019 - Springer
Introduction Antiplatelet therapy is very important following percutaneous coronary
intervention (PCI). New generation P2Y 12 inhibitors (ticagrelor and prasugrel) might …
intervention (PCI). New generation P2Y 12 inhibitors (ticagrelor and prasugrel) might …
[HTML][HTML] Application effect of evidence-based nursing in perioperative period of acute coronary syndrome
J Liu, Z Zhong, S Ou, K Peng - American Journal of translational …, 2021 - ncbi.nlm.nih.gov
Objective: To investigate the effect of evidence-based nursing on anxiety and depression,
sleep quality and life quality of patients with acute coronary syndrome during perioperative …
sleep quality and life quality of patients with acute coronary syndrome during perioperative …
Bleeding severity in percutaneous coronary intervention (PCI) and its impact on short-term clinical outcomes
Bleeding severity in patients undergoing percutaneous coronary intervention (PCI), defined
by the Bleeding Academic Research Consortium (BARC), portends adverse prognosis. We …
by the Bleeding Academic Research Consortium (BARC), portends adverse prognosis. We …
Use of PRECISE-DAPT score and admission platelet count to predict mortality risk in patients with acute coronary syndrome
N Morici, GA Tavecchia, L Antolini, MR Caporale… - …, 2019 - journals.sagepub.com
The PREdicting bleeding Complications In patients undergoing Stent implantation and
subsEquent Dual Antiplatelet Therapy (PRECISE-DAPT) score has been validated to predict …
subsEquent Dual Antiplatelet Therapy (PRECISE-DAPT) score has been validated to predict …
Association between ticagrelor plasma concentration and bleeding events in Chinese patients with acute coronary syndrome
J Yang, G Qi, F Hu, X Zhang, Y Xing… - British Journal of …, 2022 - Wiley Online Library
Aims The risk of ticagrelor‐related bleeding events remains a major clinical concern,
especially in East Asian populations. Previous studies have reported higher ticagrelor …
especially in East Asian populations. Previous studies have reported higher ticagrelor …
Gender and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: the TROPICAL-ACS gender substudy
L Gross, D Kupka, D Trenk, T Geisler… - Thrombosis and …, 2019 - thieme-connect.com
Objectives This prespecified analysis of the TROPICAL-ACS trial aimed to assess the impact
of gender on clinical outcomes and platelet reactivity (PR) following guided de-escalation of …
of gender on clinical outcomes and platelet reactivity (PR) following guided de-escalation of …